Ansell Limited (ASX:ANN)
32.11
+0.37 (1.17%)
Jul 1, 2026, 4:10 PM AEST
Ansell Market Cap
Ansell has a market cap or net worth of 4.47 billion as of July 1, 2026. Its market cap has increased by 2.22% in one year.
Market Cap
4.47B
Enterprise Value
5.39B
Revenue
3.01B
Ranking
n/a
PE Ratio
23.06
Stock Price
32.11
Market Cap Chart
Since January 16, 1992, Ansell's market cap has decreased from 5.00B to 4.47B, a decrease of -10.51%. That is a compound annual growth rate of -0.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 4.47B | -10.39% |
| Dec 31, 2025 | 4.99B | 1.96% |
| Dec 31, 2024 | 4.89B | 56.70% |
| Dec 29, 2023 | 3.12B | -12.08% |
| Dec 30, 2022 | 3.55B | -11.25% |
| Dec 31, 2021 | 4.00B | -10.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 55.01B |
| Sigma Healthcare | 31.86B |
| Pro Medicus | 19.73B |
| Sonic Healthcare | 10.09B |
| Ramsay Health Care | 9.91B |
| Cochlear | 7.72B |
| Telix Pharmaceuticals | 5.20B |
| 4DMedical | 2.48B |